Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2011

View Archived Issues

HspB8 blocks autophagy in breast cancer cells, conferring resistance to tamoxifen

AV-7909 improves survival of ciprofloxacin-treated guinea pigs exposed to B. anthracis

AB-103 protects mice from SEB- and LPS-induced lethal shock

Bakuchiol cream is efficacious against acne in open-label trial

Etanercept demonstrates little activity to date in phase II trial in discoid lupus erythematosus

BAY-86-4367 effectively targets prostate tumors in preclinical study

Gentium completes defibrotide studies in veno-occlusive disease and prepares regulatory filings

GSK to launch new alli chewable tablet as weight loss aid

Phase IIb trial to compare delafloxacin to linezolid and vancomycin in ABSSSI

EMA grants orphan drug status to GT-038 in retinitis pigmentosa

Treatment begins in phase I elesclomol trial in acute myeloid leukemia

CytRx reports preclinical data on bafetinib in cancer-related bone loss

Elan and Boehringer Ingelheim to codevelop antibody-based therapeutics

R-Tech Ueno begins phase I trial to test RL-023's safety as therapy for eyelash hypotrichosis

Clinuvel completes phase II Scenesse trial in erythropoietic protoporphyria

Biovail Labs acquires Canadian license for Aczone from Allergen

Pervasis Therapeutics' Vascugel receives FDA fast track status

AMAG receives NON from Health Canada regarding Feraheme submission

Johnson & Johnson reports highlights fourth quarter 2010

Circassia acquires worldwide rights to psoriasis and atopic dermatitis treatment PAP-1

A.P. Pharma provides company update

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...